Products for Research Use Only
RegisterLogin

Luspatercept

CAT: 0804-HY-P99720-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99720-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Luspatercept (ACE-536) is a recombinant modified ActRIIB fusion protein that binds with transforming growth factor β superfamily ligands. Luspatercept increases the erythrocyte numbers and promotes maturation of erythroid precursors. Luspatercept binds with GDF11 and inhibits Smad2/3 signaling. Luspatercept can be used for the research of anemia[1].
CAS Number
1373715-00-4
Product Name Alternative
ACE-536; luspatercept–aamt
UNSPSC
12352203
Target
TGF-beta/Smad
Type
Inhibitory Antibodies
Related Pathways
Stem Cell/Wnt; TGF-beta/Smad
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease; Cancer
Assay Protocol
https://www.medchemexpress.com/luspatercept.html
Purity
98.92
Solubility
10 mM in DMSO
Smiles
[Luspatercept]
Molecular Weight
(75.71 kDa)
References & Citations
[1]Suragani RN, et al. Transforming growth factor-β superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis. Nat Med. 2014 Apr;20 (4) :408-14.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Launched

Alternative Products

CatalogName
BA9084-1Luspatercept
E55B1172Luspatercept (Reference antibody)
WA3120Research Grade Luspatercept
GTR18697479-01Luspatercept Monoclonal Antibody
ICH5664-10mgLuspatercept Biosimilar - Research Grade
PX-TA2101-01Luspatercept Biosimilar - Anti-GDF11 fusion protein - Research Grade
A136251Luspatercept Biosimilar (, Fusion - [ACVR2B (activin A receptor type 2B, ActR-IIB, ActRIIB) ]2 - IGHG1 Fc (Fragment constant) )

Popular Products